Marina Montagnani Marelli

Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.

D. Dondi, Patrízia Limonta, Roberta M. Moretti et al. · PubMed · 1994 · 150 citations · Full text

Medicine, Endocrinology, Pharmacology +16

The Luteinizing Hormone-Releasing Hormone Receptor in Human Prostate Cancer Cells: Messenger Ribonucleic Acid Expression, Molecular Size, and Signal Transduction Pathway1

Patrízia Limonta, Roberta M. Moretti, Marina Montagnani Marelli et al. · Endocrinology · 1999 · 127 citations

Life Sciences, Endocrinology, Molecular Biology +17

Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells

Riccardo Cristofani, Marina Montagnani Marelli, M.E. Cicardi et al. · Cell Death and Disease · 2018 · 121 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

δ‐Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells

Fabrizio Fontana, Roberta M. Moretti, M. Raimondi et al. · Cell Proliferation · 2019 · 108 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.

Roberta M. Moretti, Marina Montagnani Marelli, D. Dondi et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 90 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16